Protocol I7C-MC-FEAC A Multiple-Dose Dose-Escalation Study to Evaluate the Safety Tolerability Pharmacokinetics and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to investigate multiple ascending doses of LY3113593 to assess the safety and tolerability and the effect on hematology pharmacodynamic markers when LY3113593 is administered as repeated IV infusions in anemic patients with chronic kidney disease receiving hemodialysis.
Description
The purpose of this study is to investigate multiple ascending doses of LY3113593 to assess the safety and tolerability and the effect on hematology pharmacodynamic markers when LY3113593 is administered as repeated IV infusions in anemic patients with chronic kidney disease receiving hemodialysis.
Details
| Condition | chronic kidney disease |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX5555 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.